Fosphenytoin Sodium
Who holds supplier records for Fosphenytoin Sodium? 5 organisations hold a current record for Fosphenytoin Sodium: an active US FDA Type II Drug Master File. A further 5 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2) and France (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Fosphenytoin Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/fosphenytoin-sodium
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fosphenytoin Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHEMWERTH INCFranceActive DMF 37565 · latest filing Mar 2023
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 33756 · latest filing Apr 2019
- GUANG'AN KINGDAY PHARMA AND CHEM CO LTDActive DMF 32816 · latest filing Aug 2018
- SHANGHAI ZIYUAN PHARMACEUTICAL CO LTDActive DMF 17333 · latest filing Apr 2004
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 19455 · latest filing May 2006
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (5)
Organisations whose Type II DMFs for Fosphenytoin Sodium are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- Italy · Inactive DMF 20970 · filed Oct 2007
- India · Inactive DMF 20511 · filed May 2007
- Switzerland · Inactive DMF 18954 · filed Nov 2005
- India · Inactive DMF 18806 · filed Sept 2005
- Italy · Inactive DMF 16899 · filed Oct 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Fosphenytoin Sodium is a water-soluble prodrug of phenytoin, commonly used for the management of epilepsy and seizures. It is preferred under emergency situations where intravenous or intramuscular administration is required, as it is rapidly converted to the active drug, phenytoin, after administration.
Chemical identity
- IUPAC name
- disodium;(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate
- Canonical SMILES
- C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)([O-])[O-])C3=CC=CC=C3.[Na+].[Na+]
- InChIKey
- GQPXYJNXTAFDLT-UHFFFAOYSA-L
- Synonyms
- Cerebyx API, acc-9653-010 (sodium salt), cerebyx, ci 982, ci-982, fosphenytoin disodium salt, pro-epanutin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Anti-epileptic Agent
- Mechanism of action
- Cytochrome P450 1A2 Inducers; Cytochrome P450 2B6 Inducers; Cytochrome P450 2C19 Inducers; Cytochrome P450 2C8 Inducers; Cytochrome P450 2C9 Inducers; Cytochrome P450 2D6 Inducers; Cytochrome P450 3A Inducers
- Physiologic effect
- Decreased Central Nervous System Disorganized Electrical Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fosphenytoin Sodium?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Fosphenytoin Sodium: CHEMWERTH INC (France), GLAND PHARMA LTD (India), GUANG'AN KINGDAY PHARMA AND CHEM CO LTD, SHANGHAI ZIYUAN PHARMACEUTICAL CO LTD and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fosphenytoin Sodium Drug Master Files are active?
CHEMWERTH INC (DMF 37565), GLAND PHARMA LTD (DMF 33756), GUANG'AN KINGDAY PHARMA AND CHEM CO LTD (DMF 32816), SHANGHAI ZIYUAN PHARMACEUTICAL CO LTD (DMF 17333) and Sun Pharmaceutical Industries Limited (DMF 19455). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fosphenytoin Sodium records mean?
5 organisations have only inactive Type II DMFs for Fosphenytoin Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Fosphenytoin Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fosphenytoin Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.